Furthermore, we used GEPIA2 to examine the association between SLC31A1 expression and pathological stages of tumors and found a significant difference of SLC31A1 expression among pathological stages of ACC, KIRC, and MESO (all P < 0.05) (Additional file 2: Figure S2). The gene discussed is SLC31A1; the disease is adrenal cortex carcinoma.